ged 4 to 18 years cut their salt intake by half (i.e., an
average reduction of 3 grams a day), there would be a decrease of
approximately two sugar-sweetened soft drinks per week per child, so each
child would decrease calorie intake by almost 250 kcal per week," Dr. He
said. "Not only would reducing salt intake lower blood pressure in
children, but it could also play a role in helping to reduce obesity."
In previous studies, researchers found that a modest reduction in
dietary salt intake lowers blood pressure in children, and a low-salt diet
during childhood may prevent the development of high blood pressure later
in life (Reference: He FJ, MacGregor GA. Importance of salt in determining
blood pressure in children: meta-analysis of controlled trials.
Hypertension. 2006;48:861-869).
The new research suggests that reduced salt intake could also help
decrease childhood obesity, through its effect on sugar-sweetened soft
drink consumption.
"Both high blood pressure and obesity increase the risk of having
strokes and heart attacks," Dr. He said. "It is, therefore, important for
children to eat a low-salt diet to reduce their risk of having a stroke or
a heart attack later in life. All physicians should give their patients
appropriate advice on how to reduce salt in their diet."
Dr. He recommends that parents check labels, choose low-salt food
products and not add salt during cooking and at the table.
She also urges consumers to challenge the food industry to make a
gradual and sustained reduction in the amount of salt added to children's
food products that have added salt.
In most developed countries, about 80 percent of salt intake is from
salt already added to food by the food industry. Reducing salt would not
necessarily impact food taste, she said.
"Small reductions in the salt content of 10 percent to 20 percent
cannot be detected by the human salt taste receptors and do not cause any
technological or
'/>"/>
SOURCE American Heart Association Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine technology :1.
Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA2.
Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate3.
GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.4.
Aspirin Named 8th World Wonder by Majority of Americans5.
MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study6.
American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?7.
TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site8.
Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care9.
Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting10.
Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers11.
New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting